Ovarian cancer is among the most lethal gynecological cancers because it is often detected at an advanced stage and can be ...
Preliminary research indicates cannabis compounds cannabidiol and Δ9-tetrahydrocannabinol could have potential in treating ...
Cannabis Compounds Reveal Potent Action On Ovarian Cancer. Laboratory research has found that two well-known cannabis compounds, cannabidiol and tetrahydrocannabinol, can sharply curb the growth and ...
Atezolizumab plus standard therapy was not associated with improved survival in advanced recurrent ovarian cancer.
In premenopausal women with early breast cancer, survival is not affected by fertility preservation procedures, researchers report.
Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...
The World Ovarian Cancer Coalition announced that a groundbreaking international study, "Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Wo ...
Clinical Trials Arena on MSN
Daiichi Sankyo announces first patient dosed in phase III trial of Enhertu
Daiichi Sankyo has announced the dosing of first patient in the DESTINY-Ovarian01 Phase III trial’s randomisation phase, ...
Philadelphia, PA, USA, December 9, 2025, First Patient Enrolled in GOG-3133/ FRAmework-01 Phase 3 Study Evaluating Sofetabart ...
FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.
Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...
-- ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025 -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback